Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb;8(1):76-83.
doi: 10.2353/jmoldx.2006.040402.

Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma

Affiliations

Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma

Adam Steg et al. J Mol Diagn. 2006 Feb.

Abstract

Recent studies have shown the hedgehog and Wnt families of signaling proteins to be associated with tumor initiation, growth, and survival. However, these pathways remain unexplored in ovarian endometrioid adenocarcinoma (OEA). Here, we describe a novel TaqMan low-density array to examine the expression of 26 and 20 genes in the hedgehog and Wnt pathways, respectively, in six matched snap-frozen and formalin-fixed, paraffin-embedded (FPE) OEA specimens. Expression values were normalized to uninvolved ovarian epithelium. Gene expression in matched frozen and FPE tissues demonstrated significant concordance (r = 0.92, P < 0.0001). However, comparison of amplified and unamplified RNA from frozen OEA tissues revealed an altered molecular profile in amplified RNA. Amplification of RNA from FPE tissues was not successful. The expression of Desert hedgehog (DHH), Indian hedgehog (IHH), Hedge-hog interacting protein (HHIP), Wnt10B, Wnt9B, and Wnt inhibitory factor (WIF1) were tumor-specific with no detectable expression in normal ovarian epithelium. In addition, several genes were significantly (P < 0.025) down-regulated in OEA, including cyclin E2, Porcupine, c-Myc, and Axin 2 (4.8-, 3.6-, 2.9-, and 1.9-fold, respectively). TaqMan low-density array provides an effective multivariate technique for examining gene expression in RNA isolated from either snap-frozen or archival FPE tissues and can identify tumor-specific genes, possibly leading to novel treatments.

PubMed Disclaimer

Figures

Figure 1
Figure 1
TLDA design using a 48-gene template.
Figure 2
Figure 2
Correlative plot of mean ΔCT values obtained by TLDA analysis of 48 genes in six frozen (x) compared to six matching paraffin-embedded OEA samples (y). Regression analysis demonstrated a coefficient of determination (r2) of 0.85 and a Pearson correlation coefficient (r) of 0.92 (P < 0.0001).
Figure 3
Figure 3
Correlative plot of CT values obtained by TLDA analysis of 48 genes in amplified (x) compared to unamplified (template) (y) using the Ovation Nanosample RNA amplification system with a coefficient of determination (r2) of 0.30 and a Pearson correlation coefficient (r) of 0.53 (P < 0.0001) (A); and the Full Spectrum Global RNA amplification kit with a coefficient of determination (r2) of 0.56 and a Pearson correlation coefficient (r) of 0.75 (P < 0.0001) (B).
Figure 4
Figure 4
Correlative plot of ΔCT values obtained by RTQ analysis of eight genes (DHH, IHH, SHH, PTCH, PTCH2, SMO, GLI, GLI3) in six frozen (x) compared to six matching paraffin-embedded OEA samples (y). Regression analysis demonstrated a coefficient of determination (r2) of 0.83 and a Pearson correlation coefficient (r) of 0.91 (P < 0.0001).

Similar articles

Cited by

References

    1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33. - PubMed
    1. Engel J, Eckel R, Schubert-Fritschle G, Kerr J, Kuhn W, Diebold J, Kimmig R, Rehbock J, Holzel D. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer. 2002;38:2435–2445. - PubMed
    1. Goodman MT, Correa CN, Tung KH, Roffers SD, Cheng Wu X, Young JL, Jr, Wilkens LR, Carney ME, Howe HL. Stage at diagnosis of ovarian cancer in the United States, 1992–1997. Cancer. 2003;97:2648–2659. - PubMed
    1. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol. 1996;23:40–47. - PubMed
    1. Wicking C, Smyth I, Bale A. The hedgehog signalling pathway in tumorigenesis and development. Oncogene. 1999;18:7844–7851. - PubMed

Publication types

MeSH terms